Key result
Statins and PPAR agonists suppress platelet-induced foam cell differentiation via MMP-9 inhibition.
Answers are grounded in this paper and cite their sources.
Platelet interaction with circulating progenitor cells plays an important role for repair mechanisms at sites of vascular lesions. Foam cell formation represents a key process in atherosclerotic plaque formation. We revealed that platelets regulate recruitment and differentiation of CD34 (+) progenitor cells into foam cells and endothelial cells. Adhesion studies showed that platelets recruit CD34 (+) progenitor cells via specific adhesion receptors, including P-selection/P-selectin glycoprotein ligand 1, and beta (1) and beta (2) integrins. CD34 (+) progenitor cells were coincubated with human platelets for 1 week. We demonstrated that a substantial number of CD34 (+) cells differentiated into foam cells. Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) and agonists of peroxisome proliferator-activated receptor-alpha and -gamma (PPAR-alpha and -gamma agonists) reduced this foam cell generation via inhibition of matrix metalloproteinase 9 secretions. Foam cell formation is also induced by low-density lipoproteins (LDLs). It was revealed that platelets take up modified LDL (fluorochrome-conjugated acetylated LDL) that is stored in the dense granules and internalized rapidly into the foam cells. These findings emphasize that the balance between endothelial cell regeneration and platelet-mediated foam cell generation derived from CD34 (+) progenitor cells may play a critical role in atherogenesis and atheroprogression.
No takes yet. Share an insight, caveat, or question.
Daub et al. (2007) studied Atherosclerosis. Coincubation of CD34(+) progenitor cells with human platelets (and treatment with statins or PPAR-alpha/-gamma agonists) was evaluated on Differentiation of CD34(+) progenitor cells into foam cells and endothelial cells. Human platelets coincubated with CD34(+) progenitor cells for 1 week induced foam cell differentiation, which was reduced by statins and PPAR-alpha/-gamma agonists via MMP-9 inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: